Revenue from Contracts with Customers (Tables)

6 Months Ended

Mar. 31, 2022

Revenue from Contract with Customer [Abstract]

Revenue by Reporting Unit

	Three months ended March 31,				Six months ended March 31,
	2022		2021		2022			2021
Significant Business Line
Life Sciences Products	$	53,615	$	52,355	$	103,493	$	97,899
Sample Repository Solutions		26,929		22,191		52,805		42,724
Genomic Services		65,000		54,989		128,898		107,054
Total	$	145,544	$	129,535	$	285,196	$	247,677

Remaining Performance Obligations

	As of March 31, 2022
	Less than 1 Year		Greater than 1 Year		Total
Remaining Performance Obligations	$	41,405	$	14,300	$	55,705